Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Pain Symptom Manage. 2017 Jan 4;53(5):887–900.e2. doi: 10.1016/j.jpainsymman.2016.12.339

Table 3.

Demographic, Clinical, and Symptom Characteristics of the Patients in the Evening Energy Analysis (n=1332)

Demographic Characteristics
 Age (years; mean (SD)) 57.16 (12.39)


 Gender (% female (n)) 77.9 (1038)

 Ethnicity (% (n))
  White 69.4 (925)
  Black 9.9 (132)
  Asian/Pacific Islander 9.6 (128)
  Hispanic/Mixed/Other 11.0 (147)

 Education (years; mean (SD)) 16.18 (2.99)

 Married or partnered (% yes (n)) 65.0 (866)

 Lives alone (% yes (n)) 21.2 (283)

 Currently employed (% yes (n)) 34.8 (463)

 Child care responsibilities (% yes (n)) 21.7 (289)

 Income (% yes (n))
  Less than $30,000 18.4 (219)
  $30,000 to <$70,000 21.1 (252)
  $70,000 to < $100,000 16.9 (202)
  More than $100,000 43.5 (519)

Clinical Characteristics

 Number of comorbidities (mean (SD)) 2.40 (1.43)

 Self-administered Comorbidity Questionnaire score (mean (SD)) 5.47 (3.20)

 Body mass index (kg/m2; mean (SD)) 26.17 (5.63)

 Hemoglobin (gm/dL; mean (SD)) 11.54 (1.43)

 Karnofsky Performance Status score (mean (SD)) 80.00 (12.39)

 Have you ever considered yourself a smoker (% yes (n)) 34.8 (463)

 Exercise on a regular basis (% yes (n)) 71.5 (952)

 Specific comorbidities reported (% yes (n))
  High blood pressure 30.1 (401)
  Back pain 25.8 (343)
  Depression 19.3 (257)
  Osteoarthritis 12.0 (160)
  Anemia or blood disease 12.3 (164)
  Lung disease 11.3 (151)
  Diabetes 8.9 (119)
  Liver disease 6.5 (86)
  Heart disease 5.6 (75)
  Rheumatoid arthritis 3.1 (41)
  Ulcer or stomach disease 4.9 (65)
  Kidney disease 1.4 (19)

 Cancer diagnosis (% yes (n))
  Breast 40.4 (538)
  Gastrointestinal 30.4 (405)
  Gynecological 17.4 (232)
  Lung 11.8 (157)

 Time since cancer diagnosis (years; mean (SD)) 1.97 (3.87)

 Time since cancer diagnosis (years; median) 1.97 (0.42)

 Any prior cancer treatments (% yes (n)) 75.7 (1008)

 Number prior cancer treatments (mean (SD)) 1.59 (1.50)

 Chemotherapy cycle length (% (n))
  14 days 41.7 (556)
  21 days 51.0 (679)
  28 days 7.3 (97)

 Presence of metastatic disease (% yes (n)) 67.0 (893)

 Number of metastatic sites including lymph node involvement (mean (SD)) 1.24 (1.23)

 Number of metastatic sites excluding lymph node involvement (mean (SD)) 0.78 (1.05)

Symptom Characteristics at Enrollment

 Lee Fatigue Scale: evening fatigue score (mean (SD)) 5.33 (2.15)

 Lee Fatigue Scale: morning fatigue score (mean (SD)) 3.13 (2.25)

 Lee Fatigue Scale: evening energy score (mean (SD)) 3.54 (2.04)

 Lee Fatigue Scale: morning energy score (mean (SD)) 4.40 (2.25)

 Center for Epidemiological Studies-Depression Scale score (mean (SD)) 12.97 (9.77)

 General Sleep Disturbance Scale score (mean (SD)) 52.59 (20.19)

 Trait Anxiety score (mean (SD)) 35.15 (10.39)

 State Anxiety score (mean (SD)) 33.98 (12.33)

 Attentional Function Index score (mean (SD)) 6.38 (1.82)

 Pain present (% yes (n)) 72.8 (970)

Abbreviations: gm/dL = grams per deciliter; kg/m2 = kilograms per meters squared; SD = standard deviation; RT = radiation therapy.